Publisher of Iranian Journals and Conference Proceedings

Please waite ..
Publisher of Iranian Journals and Conference Proceedings
Login |Register |Help |عضویت کتابخانه ها
Paper
Title

Allogeneic tumor cell line-based vaccines: A good alternative to autologous and cancer stem cell vaccines in colorectal cancer

مجله علوم پایه پزشکی ایران، دوره: 24، شماره: 9
Year: 1400
COI: JR_IJBMS-24-9_009
Language: EnglishView: 86
This Paper With 9 Page And PDF Format Ready To Download

Buy and Download

با استفاده از پرداخت اینترنتی بسیار سریع و ساده می توانید اصل این Paper را که دارای 9 صفحه است به صورت فایل PDF در اختیار داشته باشید.
آدرس ایمیل خود را در کادر زیر وارد نمایید:

Authors

Fatemeh Rafieenia - Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Elham Nikkhah - Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Fatemeh Nourmohammadi - Department of Biology, Damghan branch, Islamic Azad University, Damghan, Iran
Sousan Hosseini - Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Abbas Abdollahi - Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Nourieh Sharifi - Department of Pathology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Mohsen Aliakbarian - Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Mohammad Mahdi Forghani Fard - Department of Biology, Damghan branch, Islamic Azad University, Damghan, Iran
Mehran Gholamin - Department of Laboratory Sciences, School of Paramedical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran
Mohammad Reza Abbaszadegan - Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract:

Objective(s): Besides the uncertainty about colorectal cancer stem cell (CCSC) markers, isolating, purifying, and enriching CCSCs to produce CCSC vaccines is highly challenging. However, allogeneic vaccines developed from CRC cell lines can provide universal, comprehensive, inexpensive, simple, and fast approach to cancer treatment. Materials and Methods: CCSCs were isolated from human CRC tissue using the in vitro sphere formation assay and then characterized through gene expression analysis, in vivo and in vitro tumor formation assay, karyotyping, and surface marker detection. Subsequently, CCSCs and two CRC cell lines (HT-۲۹ and SW-۴۸۰) were inactivated with cisplatin (CDDP) and administrated as vaccines to the three groups of athymic C۵۷BL/۶ nude mice. Afterward, tumorigenesis was challenged with HT-۲۹ cells. The antitumor effect of vaccines was evaluated by tumor and spleen examination and immune response analysis. The cytotoxic activity of splenocytes and serum levels of TGF-β and IFN-γ were measured by Calcein-AM cytotoxicity assay and enzyme-linked immunosorbent assay (ELISA), respectively.Results: The results of gene expression analysis showed that CCSCs are CD۴۴+CD۱۳۳-LGR۵-. All vaccinations resulted in decreased tumor growth, spleen enlargement, enhanced serum level of IFN-γ and TGF-β, and increased cytotoxic activity of natural killer (NK) cells. The antitumor efficacy of the CCSC vaccine was not more than CRC cell line-based vaccines. Interestingly, the allogeneic SW-۴۸۰ vaccine could effectively inhibit tumorigenesis.Conclusion: Despite the great challenge in developing CCSC vaccines, allogeneic vaccines based on CRC cell lines can efficiently induce antitumor immunity in CRC.

Keywords:

Paper COI Code

This Paper COI Code is JR_IJBMS-24-9_009. Also You can use the following address to link to this article. This link is permanent and is used as an article registration confirmation in the Civilica reference:

https://civilica.com/doc/1269751/

How to Cite to This Paper:

If you want to refer to this Paper in your research work, you can simply use the following phrase in the resources section:
Rafieenia, Fatemeh and Nikkhah, Elham and Nourmohammadi, Fatemeh and Hosseini, Sousan and Abdollahi, Abbas and Sharifi, Nourieh and Aliakbarian, Mohsen and Forghani Fard, Mohammad Mahdi and Gholamin, Mehran and Abbaszadegan, Mohammad Reza,1400,Allogeneic tumor cell line-based vaccines: A good alternative to autologous and cancer stem cell vaccines in colorectal cancer,https://civilica.com/doc/1269751

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, ...
  • Nguyen M, Tipping Smith S, Lam M, Liow E, Davies ...
  • Butterfield LH. Cancer vaccines. Bmj ۲۰۱۵;۳۵۰:h۹۸۸ ...
  • Chiang CL-L, Coukos G, Kandalaft LE. Whole tumor antigen vaccines: ...
  • Khan ST, Montroy J, Forbes N, Bastin D, Kennedy MA, ...
  • Yarchoan M, Huang CY, Zhu Q, Ferguson AK, Durham JN, ...
  • Wu AA, Bever KM, Ho WJ, Fertig EJ, Niu N, ...
  • Kim VM, Pan X, Soares KC, Azad NS, Ahuja N, ...
  • Srivatsan S, Patel JM, Bozeman EN, Imasuen IE, He S, ...
  • Zheng L, Edil BH, Soares KC, El-Shami K, Uram JN, ...
  • Lei X, He Q, Li Z, Zou Q, Xu P, ...
  • O’Brien CA, Kreso A, Jamieson CH. Cancer stem cells and ...
  • Li Y-f, Xiao B, Tu S-f, Wang Y-y, Zhang X-l. ...
  • Abbaszadegan MR, Bagheri V, Razavi MS, Momtazi AA, Sahebkar A, ...
  • Ghazaey S, Mirzaei F, Ahadian M, Keifi F, Semiramis T, ...
  • Jacobsen AV, Yemaneab BT, Jass J, Scherbak N. Reference gene ...
  • Dowling CM, Walsh D, Coffey JC, Kiely PA. The importance ...
  • Wu D, Wang J, Cai Y, Ren M, Zhang Y, ...
  • Monga SP, Wadleigh R, Sharma A, Adib H, Strader D, ...
  • Bagheri V, Abbaszadegan MR, Memar B, Motie MR, Asadi M, ...
  • Sheikhi A, Jafarzadeh A, Kokhaei P, Hojjat-Farsangi M. Whole tumor ...
  • Neller MA, López JA, Schmidt CW, editors. Antigens for cancer ...
  • Network CGAR, Bell D. Berchuck a., Birrer M, Chien J, ...
  • Belderbos RA, Baas P, Berardi R, Cornelissen R, Fennell DA, ...
  • Ghafar MTA, Morad MA, El-Zamarany EA, Ziada D, Soliman H, ...
  • van de Loosdrecht AA, van Wetering S, Santegoets SJ, Singh ...
  • Kajihara M, Takakura K, Ohkusa T, Koido S. The impact ...
  • Rafiq S, Hackett CS, Brentjens RJ. Engineering strategies to overcome ...
  • Chan JD, Lai J, Slaney CY, Kallies A, Beavis PA, ...
  • Umut Ö, Gottschlich A, Endres S, Kobold S. CAR T ...
  • Schoenborn JR, Wilson CB. Regulation of interferon‐γ during innate and ...
  • Fan X-S, Wu H-Y, Yu H-P, Zhou Q, Zhang Y-F, ...
  • He S, Zhou H, Zhu X, Hu S, Fei M, ...
  • Kim YJ, Kang DH, Song GJ, Ahn TS, Son MW, ...
  • Zhou X, Geng L, Wang D, Yi H, Talmon G, ...
  • Horst D, Scheel SK, Liebmann S, Neumann J, Maatz S, ...
  • Szaryńska M, Olejniczak A, Kobiela J, Łaski D, Śledziński Z, ...

Research Info Management

Certificate | Report | من نویسنده این مقاله هستم

اطلاعات استنادی این Paper را به نرم افزارهای مدیریت اطلاعات علمی و استنادی ارسال نمایید و در تحقیقات خود از آن استفاده نمایید.

Scientometrics

The specifications of the publisher center of this Paper are as follows:
Type of center: علوم پزشکی
Paper count: 8,097
In the scientometrics section of CIVILICA, you can see the scientific ranking of the Iranian academic and research centers based on the statistics of indexed articles.

Share this page

More information about COI

COI stands for "CIVILICA Object Identifier". COI is the unique code assigned to articles of Iranian conferences and journals when indexing on the CIVILICA citation database.

The COI is the national code of documents indexed in CIVILICA and is a unique and permanent code. it can always be cited and tracked and assumed as registration confirmation ID.

Support